Stanford economists Paul Milgrom and Robert Wilson win the Nobel in economic sciences
Stanford economist Paul Milgrom was not prepared for the knock on his door early Monday morning from his neighbor.
Eavesdropping on cell communications to diagnose and treat cancer earlier
An estimated 19.3 million new cancer cases and almost 10 million cancer deaths occurred worldwide in 2020.
Using brands’ high vaccination rates as a marketing tool
Opinion: In part two, Mike Lee looks at how businesses can help increase vaccination rates and operate to keep staff, livelihood, and other customers “free from harm”.
Missing a deadline has a bigger impact than you might think: Study
People who were told work was submitted late considered it to be of lower quality than the same work submitted early or on time.
Ravenscar House Museum: A remarkable gift to Ōtautahi
When Ōtautahi Christchurch’s striking purpose-built Ravenscar House Museum opened to the public late last year, it was the realisation of a long-held dream.
Drug Trends Survey shows increase in cannabis availability, while meth prices continue to drop
Findings from the 2022/23 New Zealand Drugs Trends Survey show a sharp increase in cannabis availability and decrease in price, as well as an ongoing decline in the price of methamphetamine.
Liver can generate palmitic acid to maintain brain health, study suggests
Researchers at the University of Toronto have found that palmitic acid, one of the most common fats in human milk, meats and dairy products, is made by the liver and sent to the developing brain when it’s low in the diet.
Helicopter to attempt first trip on Mars surface
The first helicopter ever to fly on another planet will soon attempt its first trip above the surface of Mars.
Gene therapy gives families hope for babies with spinal muscular atrophy
A trial has revealed that babies with SMA treated with gene therapy are meeting the normal developmental milestones of any baby.
UNSW neuroscientist receives an inaugural $1.35m Rebecca Cooper Fellowship
Researchers will examine new treatments to improve outcomes for people with advanced kidney disease and those who have experienced an ischaemic stroke.